Delivery Order SPE2DB25D7060-SPE2DB25FXSQD
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,285,521 units of Hydroxyzine 10 mg/5 ml Syrup in 473 ml bottles. The contract is a firm-fixed-price delivery order with a ceiling value of $13,629.07 and an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563343774 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, with a ceiling value of $3,388.40 and a performance period through January 18, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxyzine 50 mg/ml vials, with a total ceiling value of $1,205.50 and an ultimate completion date of July 3, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $25,941.49, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4,565,286,888 units of 10 mg/5 ml Hydroxyzine Syrup in 473 ml bottles. The award has an ultimate completion date of July 30, 2024 and is a Firm Fixed Price contract. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,969,432 milliliters of hydroxyzine 10 milligram per 5 milliliter syrup in 473 milliliter bottles, with a ceiling value of $1,164.04 and a period of performance through March 15, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,429.66, is for the delivery of 4563267261 Hydroxyzine 10 mg/5 ml Syrup 473 ml. It is a firm fixed price delivery order contract with a completion date of January 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,113.27, is for the supply of 4565110793 - Hydroxyzine 10 mg/5 ml syrup (473 ml). The award does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,795,203 bottles of 473 mL Hydroxyzine 10 mg/5 mL Syrup. The contract, valued at $1,319.37, is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 5, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, without the use of any set-aside designations. Amerisourcebergen, one of the largest pharmaceutical...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,554.96 firm fixed-price delivery order is for the supply of 4564450204 - Hydroxyzine 10 mg/5 ml Syrup 473 ml, with a completion date of May 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,152.12 and is a Firm Fixed Price Delivery Order for the supply of 4563850006 - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract has an ultimate completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSQDDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 473 ml bottles of 10 mg/5 ml Hydroxyzine syrup, with a ceiling value of $3,059.36 and a completion date of July 18, 2025. The contract is not a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts, potentially involving multiple regional awards, which may further expand Amerisourcebergen's role as a key federal medical supplier.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/17/25 |